Skip to main content

Advertisement

Log in

Public Health Department Response to Mercury Poisoning: The Importance of Biomarkers and Risks and Benefits Analysis for Chelation Therapy

  • Proceedings
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Chelation therapy is often used to treat mercury poisoning. Public health personnel are often asked about mercury toxicity and its treatment. This paper provides a public health department response to use of a mercury-containing cosmetic in Minnesota, a perspective on two unpublished cases of chelation treatment for postulated mercury toxicity, and comments on the use of a nonsystemic treatment for removal of mercury following the Iraqi seed coat poisoning incident. Physicians should evaluate sources of exposure, biomarkers, and risks and benefits before recommending chelation therapy for their patients. Potential risks to chelation therapy and its little understood subtle or latent effects are areas of public health concern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fish Consumption Advise. Minnesota Department of Health. Available at: http://www.health.state.mn.us/divs/eh/fish/index.html. Accessed August 2013

  2. Choi-Lao ATH, Corte G, Dowd G, Lao RC (1979) Mercury vapor as a contaminant of hospital environment. Sci Total Environ 11(3):287–292

    Article  PubMed  CAS  Google Scholar 

  3. Task Force on Ritualistic Uses of Mercury Report. Office of Emergency and Remedial Response; United States Environmental Protection Agency. December 2002. Available at: http://www.epa.gov/superfund/community/pdfs/mercury.pdf. Accessed August 2013

  4. Warkany J. Acrodynia—Postmortem of a Disease. Am J Dis Child 1966;112(2):146–156. Available at: http://archpedi.jamanetwork.com/article.aspx?articleid=501896. Accessed August 2013

    Google Scholar 

  5. Mercury exposure from interior latex paint – Michigan. MMWR 1990;39(8):125–126. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00001566.htm. Accessed August 2013

  6. Minnesota Department of Health and the MN Regional Poison Center. Mercury exposure from Skin-Lightening Products Fact Sheet for Health Care Providers. 2011. Available at: http://www.health.state.mn.us/topics/skin/provfs.pdf and http://www.health.state.mn.us/topics/skin/ Accessed August 2013

  7. Copan L, Ujihara A, Jones C, Das R, Kreutzer R et al (2012) Mercury exposure among household users and nonusers of skin-lightening creams produced in Mexico—California and Virginia, 2010. MMWR 61:33–36

    Google Scholar 

  8. Harada M (1995) Minamata disease: methyhlmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 25(1):1–24

    Article  PubMed  CAS  Google Scholar 

  9. Skerfving SB, Copplestone JF. Poisoning caused by the consumption of organomercury-dressed seed in Iraq. Bull World Health Organ 1976;54:101–112. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366450/pdf/bullwho00452-0108.pdf. Accessed August 2013

  10. von Mühlendahl K (1990) Intoxication from mercury spilled on carpets. Lancet 336(8730):1578

    Article  Google Scholar 

  11. Velzeboer S, Frenkel J, de Wolff F (1997) A hypertensive toddler. Lancet 349(9068):1810

    Article  PubMed  CAS  Google Scholar 

  12. Chrysochoou C, Rutishauser C, Rauber-Luthy C, Neuhaus T, Boltshauser E, Superti-Furga A (2003) An 11-month-old boy with psychomotor regression and auto-aggressive behaviour. Eur J Pediatr 162:559–561

    Article  PubMed  Google Scholar 

  13. Clarkson TW, Magos L, Cox C, Greenwood MR, Amin-Zaki L et al (1981) Tests of efficacy of antidotes for removal of methylmercury in human poisoning during the Iraq outbreak. J Pharmacol Exp Ther 218(1):74–83

    PubMed  CAS  Google Scholar 

  14. Norseth T, Clarkson TW (1970) Studies on the biotransformation of 203Hg-labeled methyl mercury chloride in rats. Arch Environ Health 21(6):717–727

    Article  PubMed  CAS  Google Scholar 

  15. US Environmental Protection Agency (2001) Water quality criterion for the protection of human health: methylmercury Chapter 4: risk assessment for methylmercury. Office of Science and Technology, Office of Water, Washington, D.C, EPA-823-R-01-001, January 2001

    Google Scholar 

Download references

Acknowledgment

This publication was supported by the cooperative agreement award number 1U61TS000117-04 from the Agency for Toxic Substances and Disease Registry (ATSDR). Its contents are the responsibility of the authors and do not necessarily represent the official views of the Agency for Toxic Substances and Disease Registry (ATSDR).

Conflict of Interest

For the work under consideration for publication, Dr. McKay received a consulting fee/honorarium and reimbursement for travel through the ACMT/ATSDR Cooperative Agreement. Relevant financial activities outside the submitted work included money paid by the state DPH and various private attorney’s firms to Dr. McKay and to Dr. McKay’s institution for consulting on cases involving chelation issues. Dr. McKay is on the Scientific Advisory Council for the Environmental Health Research Foundation, which addresses issues related to biomonitoring for environmental chemicals. Dr. Herbrandson received reimbursement for travel to the conference through the ACMT/ATSDR Cooperative Agreement.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles A. McKay Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKay, C.A. Public Health Department Response to Mercury Poisoning: The Importance of Biomarkers and Risks and Benefits Analysis for Chelation Therapy. J. Med. Toxicol. 9, 308–312 (2013). https://doi.org/10.1007/s13181-013-0340-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-013-0340-9

Keywords

Navigation